Carregant...
Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions
CONTEXT: Coronary artery disease is highly prevalent among patients with end stage renal disease/hemodialysis (ESRD/HD) and coronary percutaneous interventions (PCI) has been increased by nearly 50% over the past decade. After PCI with stent placement, guidelines recommend dual antiplatelet therapy...
Guardat en:
| Publicat a: | Nephrourol Mon |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Kowsar
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623612/ https://ncbi.nlm.nih.gov/pubmed/26528445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/numonthly.28099 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|